Characterisation of a functional intronic polymorphism in the human growth hormone (gh1) gene

Human Genomics

Volumn 4, Issue 5, 2010, Pages 289-301

  Millar, David S ^a   Horan, Martin ^a,b   Chuzhanova, Nadia A ^c   Cooper, David N ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c NOTTINGHAM TRENT UNIVERSITY   (United Kingdom)

Author keywords

Alternative splicing; Gene expression; Growth hormone (gh1) gene; Intronic functional polymorphism; Protein secretion

Indexed keywords

HUMAN GROWTH HORMONE;

ALLELE; ALTERNATIVE RNA SPLICING; ANIMAL; ARTICLE; CAUCASIAN; CELL LINE; DNA FLANKING REGION; GENE EXPRESSION REGULATION; GENE LINKAGE DISEQUILIBRIUM; GENETICS; GROWTH HORMONE SECRETING CELL; HAPLOTYPE; HUMAN; INTRON; METABOLISM; MOLECULAR EVOLUTION; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PROMOTER REGION; RAT; RNA SPLICING; SEQUENCE HOMOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM;

3' FLANKING REGION; ALLELES; ALTERNATIVE SPLICING; ANIMALS; BASE SEQUENCE; CELL LINE; CONSERVED SEQUENCE; EUROPEAN CONTINENTAL ANCESTRY GROUP; EVOLUTION, MOLECULAR; GENE EXPRESSION REGULATION; HAPLOTYPES; HUMAN GROWTH HORMONE; HUMANS; INTRONS; LINKAGE DISEQUILIBRIUM; MOLECULAR SEQUENCE DATA; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RATS; RNA SPLICE SITES; SEQUENCE HOMOLOGY, NUCLEIC ACID; SOMATOTROPHS;

EID: 79952278202     PISSN: 14739542     EISSN: 14797364     Source Type: Journal    
DOI: 10.1186/1479-7364-4-5-289     Document Type: Article

References (37)

1. Kaplan, S.L. (1999), ?Hormonal regulation of growth and metabolic effects of growth hormone?, in: Handbook of Physiology, Section 7, The Endocrine System (Vol. V), Hormonal Control of Growth, Kostyo, J.L., H.M. and Goodman, H.M. (eds), Oxford University Press, New York, NY, pp. 129-143.
2. Waters, M.J., Hoang, H.N., Fairlie, D.P., Pelekanos, R.A. et al. (2006), ?New insights into growth hormone action?, J. Mol. Endocrinol. Vol. 36, pp. 1-7.
3. Procter, A.M., Phillips, J.A.,and Cooper, D.N. (1998), ?The molecular genetics of growth hormone deficiency?, Hum. Genet. Vol. 103, pp. 255-272.
4. Giordano, M., Marchetti, C., Chiorboli, E., Bona, G. et al. (1997), ?Evidence for gene conversion in the generation of extensive polymorphism in the promoter of the growth hormone gene?, Hum. Genet. Vol. 100, pp. 249-255.
5. Wagner, J.K., Eblé, A., Cogan, J.D., Prince, M.A. et al. (1997), ?Allelic variations in the human growth hormone-1 gene promoter of growth hormone-deficient patients and normal controls?, Eur. J. Endocrinol. Vol. 137, pp. 474-481.
6. Horan, M., Millar, D.S., Hedderich, J., Lewis, G. et al. (2003), ?Human growth hormone 1 (GH1) gene expression: Complex haplotypedependent influence of polymorphic variation in the proximal promoter and locus control region?, Hum. Mutat. Vol. 21, pp. 408-423.
7. Wolf, A., Millar, D.S., Caliebe, A., Horan, M. et al. (2009), ?A gene conversion hotspot in the human growth hormone (GH1) gene promoter?, Hum. Mutat. Vol. 30, pp. 239-247.
8. Hasegawa, Y., Fujii, K., Yamada, M., Igarashi, Y. et al. (2000), ?Identification of novel human GH-1 gene polymorphisms that are associated with growth hormone secretion and height?. J. Clin.Endocrinol. Metab. Vol. 85, pp. 1290-1295.
9. Le Marchand, L., Donlon, T., Seifried, A., Kaaks, R. et al. (2002), ?Association of a common polymorphism in the human GH1 gene with colorectal neoplasia?, J. Natl. Cancer Inst. Vol. 94, pp. 454-460
10. Dennison, E.M., Syddall, H.E., Rodriguez, S., Voropanov, A. et al.(2004), ?Polymorphism in the growth hormone gene, weight in infancy, and adult bone mass?, J. Clin. Endocrinol. Metab. Vol. 89, pp. 4898-4903.
11. Millar, D.S., Lewis, M.D., Horan, M., Newsway, V. et al. (2003), ?Novel mutations of the growth hormone 1 (GH1) gene disclosed by modulations of the clinical selection criteria for individuals with short stature?, Hum. Mut. Vol. 21, pp. 424-440.
12. Tashjian, A.H., Yasumura, Y., Levine, L., Sato, G.H. et al. (1968), ?Establishment of clonal strains of rat pituitary tumor cells that secrete growth hormone?, Endocrinology Vol. 82, pp. 342-352.
13. Laird, P.W., Zijderveld, A., Linders, K., Rudnicki, M.A. et al. (1991), ?Simplified mammalian DNA isolation procedure?, Nucleic Acids Res. Vol.19, p. 4293.
14. Wang, M. and Marín, A. (2006), ?Characterization and prediction of alternative splice sites?, Gene Vol. 366, pp. 219-227.
15. Matys, V., Kel-Margoulis, O.V., Fricke, E., Liebich, I. et al. (2006), ?TRANSFAC and its module TRANSCompel: Transcriptional gene regulation in eukaryotes?, Nucleic Acids Res. Vol. 34(Database issue): D108-110.
16. Bourdon, J.C., Deguin-Chambon, V., Lelong, J.C., Dessen, P. et al.(1997), ?Further characterisation of the p53 responsive element-Identification of new candidate genes for trans-Activation by p53?, Oncogene Vol. 14, pp. 85-94.
17. Trujillo, M.A., Sakagashira, M. and Eberhardt, N.L. (2006), ?The human growth hormone gene contains a silencer embedded within an Alu repeat in the 3?-flanking region?, Mol. Endocrinol. Vol. 20, pp. 2559-2575.
18. Cardinaux, J.-R., Chapel, S. and Wahli, W. (1994), ?Complex organization of CTF/NF-I, C/EBP, and HNF3 binding sites within the promoter of the liver-specific vitellogenin gene?. J. Biol. Chem. Vol. 269, pp. 32947-32956.
19. Giordano, M., Godi, M., Mellone, S., Petri, A. et al. (2008), ?A functional common polymorphism in the vitamin D-responsive element of the GH1 promoter contributes to isolated growth hormone deficiency?, J. Clin. Endocrinol. Metab. Vol. 93, pp. 1005-1012.
20. Bancroft, F.C., Levine, L. and Tashjian, A.H. (1969), ?Control of growth hormone production by a clonal strain of rat pituitary cells?, J. Cell Biol. Vol. 43, pp. 432-441.
21. Giordano, M., Godi, M., Giacopelli, F., Lessi, M. et al. (2006), ?A variation in a Pit-1 site in the growth hormone gene (GH1) promoter induces a differential transcriptional activity?, Mol. Cell. Endocrinol. Vol. 249, pp. 51-57.
22. Baris, D., Gridley, G., Ron, E., Weiderpass, E. et al. (2002), ?Acromegaly and cancer risk: A cohort study in Sweden and Denmark?, Cancer Causes Control Vol. 13, pp. 395-400.
23. Jenkins, P.J., Frajese, V., Jones, A.M., Camacho-Hubner, C. et al. (2000), ?Insulin-like growth factor I and the development of colorectal neoplasia in acromegaly?, J. Clin. Endocrinol. Metab. Vol. 85, pp. 3218-3221.
24. Cohen, P., Clemmons, D.R. and Rosenfeld, R.G. (2000), Does the GH-IGF axis play a role in cancer pathogenesis, Growth Horm. IGF Res. Vol. 10, pp. 297-305.
25. Smith, J.C., Evans, L.M., Wilkinson, I., Goodfellow, J. et al. (2002), ?Effects of GH replacement on endothelial function and large-Artery stiffness in GH-deficient adults: A randomized double-blind, placebocontrolled study?, Clin. Endocrinol. Vol. 56, pp. 493-501.
26. Napoli, R., Guardasole, V., Angelini, V., D?Amico, F. et al. (2003), ?Acute effects of growth hormone on vascular function in human subjects?, J. Clin. Endocrinol. Metab. Vol. 88, pp. 2817-2820.
27. Horan, M., Newsway, V., Lewis, M.D., Easter, T.E. et al. (2006), ?Genetic variation at the growth hormone (GH1) and growth hormone receptor (GHR) loci as a risk factor for hypertension and stroke?, Hum. Genet. Vol. 119, pp. 527-540.
28. De Groof, F., Joosten, K.F.M., Janssen, J.A.M.J.L., De Kleijn, E.D. et al. (2002), ?Acute stress response in children with meningococcal sepsis: Important differences in the growth hormone/insulin-like growth factor I axis between nonsurvivors and survivors?, J. Clin. Endocrinol. Metab. Vol. 87, pp. 3118-3124.
29. Takala, J., Ruokonen, E., Webster, N.R., Nielsen, M.S. et al. (1999), ?Increased mortality associated with growth hormone treatment in critically ill adults?, N. Engl. J. Med. Vol. 341, pp. 785-792.
30. Courtois, S.J., Lafontaine, D.A., Lemaigre, F.P., Durviaux, S.M. et al. (1990), ?Nuclear factor-1 and activator protein-2 bind in a mutually exclusive way to overlapping promoter sequences and trans-Activate the human growth hormone gene?, Nucleic Acids Res. Vol. 18, pp. 57-64.
31. Alonso, M., Segura, C., Dieguez, C. and Perez-Fernandez, R. (1998), ?High-Affinity binding sites to the vitamin D receptor DNA binding domain in the human growth hormone promoter?, Biochem. Biophys. Res. Commun. Vol. 247, pp. 882-887.
32. Seoane, S., Alonso, M., Segura, C. and Perez-Fernandez, R. (2002), ?Localization of a negative vitamin D response sequence in the human growth hormone gene?, Biochem. Biophys. Res. Commun. Vol. 292, pp. 250-255.
33. Hull, J., Campino, S., Rowlands, K., Chan, M.S. et al. (2007), ?Identification of common genetic variation that modulates alternative splicing?, PLoS Genet. Vol. 3, p. e99.
34. Kwan, T., Benovoy, D., Dias, C., Gurd, S. et al. (2008), ?Genome-wide analysis of transcript isoform variation in humans?, Nat. Genet. Vol. 40, pp. 225-231.
35. Choi, J.W., Park, C.S., Hwang, M., Nam, H.Y. et al. (2008), ?A common intronic variant of CXCR3 is functionally associated with gene expression levels and the polymorphic immune cell responses to stimuli?, J. Allergy Clin. Immunol. Vol. 122, ppp. 1119-1126.e7.
36. Ragvin, A., Moro, E., Fredman, D., Navratilova, P. et al. (2010), ?Long-range gene regulation links genomic type 2 diabetes and obesity risk regions to HHEX, SOX4, and IRX3?, Proc. Natl. Acad. Sci.USAVol. 107, pp. 775-780.
37. Esteban, C., Audi, L., Carrascosa, A., Fernandez-Cancio, M. et al. (2007), ?Human growth hormone (GH1) gene polymorphism map in a normalstatured adult population?, Clin. Endocrinol. (Oxf ). Vol. 66, pp. 258-268.